Tumor radioimaging

Radioimmunoimaging (RII) is an anti-tumor antibody or a fragment thereof used as a specific targeting vehicle to cross-link diagnostic radionuclides to locate tumor tissues. Nuclear medicine imaging equipment is used to detect tumor locations in vitro Nuclear medicine diagnostic technology. A radionuclide-labeled specific antibody against tumor antigen is introduced into the body through a certain route, which will bind to the antigen on the surface of tumor cells and increase the radioactive accumulation in tumor tissue.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.